Moss Genomics Reports Bitcoin Cash (BCH) Mining Activity
Vancouver, British Columbia--(Newsfile Corp. - January 5, 2026) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") has announced it has mined a block on the Bitcoin Cash ("BCH") blockchain using proprietary mining infrastructure operated by the Company. BCH block #931,986 was mined on Jan 1, 2026 with miner ID "MOSS" included in the coinbase signature. This mining activity represents the Company's first operation in the Bitcoin ecosystem. As a team with...
2026-01-05 9:29 AM EST
Moss Genomics Announces Closing of Financing Round
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") announces that, effective as of November 11, 2025, it has closed a non-brokered private placement of 555,555 common shares at $0.18 per share for gross proceeds of $100,000. No finder's fees were paid. Net proceeds will be used for general working capital. In addition, effective as of November 11, 2025, Moss issued an aggregate 5,164,213 common...
2025-11-12 7:01 PM EST
Moss Genomics Advances Blockchain Integration Strategy
Vancouver, British Columbia--(Newsfile Corp. - July 10, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is providing an update on its Ethereum (ETH) Treasury Strategy. As part of this strategy, the Company has contributed 200 ETH with a commitment to contribute an additional 800 ETH to the presale of STRAT, an on-chain smart contract that enables ETH-based capital flows through algorithmic expansion and redemption mechanisms. This contribution...
2025-07-10 7:33 PM EDT
Moss Genomics Announces Strategic Investment in Genomes.io
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is pleased to announce that on June 18, 2025, it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io Ltd. ("Genomes.io"), a UK-based company focused on secure, user-owned genomic data storage leveraging blockchain infrastructure. Under the terms of the proposed investment, Moss would acquire a...
2025-06-19 8:00 AM EDT
Moss Genomics Launches "Perennial" Genomics Platform, Closes on 130 ETH
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the "Company" or "Moss") is pleased to announce the public launch of its genomics platform "Perennial", and closing on 130 ETH as part of its ongoing private placement. Public Launch of Perennial Moss is pleased to announce the public launch of its new genomics platform, "Perennial". The platform allows users to upload standard blood test results and receive deep insights...
2025-04-28 7:00 AM EDT
Moss Genomics Announces Listing on the OTC Markets
Vancouver, British Columbia--(Newsfile Corp. - April 11, 2025) - Moss Genomics Inc. (CSE: MOSS) (OTCQB: MSSGF) (FSE: F73) (the "Company" or "Moss") is pleased to announce that its common shares are now listed for trading on the OTC Markets under the ticker MSSGF. This milestone significantly expands Moss's accessibility for U.S.-based investors and enhances overall share liquidity by enabling trading through U.S. broker-dealers. The listing on the OTC Markets is part of Moss's broader...
2025-04-11 7:00 AM EDT
Moss Genomics Inc. Announces Leadership Changes
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) ("Moss" or the "Company") is pleased to announce the appointment of Joseph De Pinto to its Board of Directors and Michal "Mickey" Goldstein as its new fractional Chief Financial Officer (CFO). Having served as a co-founder in several blockchain-based companies as well as Barpay, which pioneered digital payments at over 15,000 bars and restaurants over the past decade, Mr. De Pinto...
2025-02-26 9:00 AM EST
Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss Genomics") is pleased to provide an update on its business strategy and the continued development of its genomics-focused initiatives. As the Company advances its product roadmap, it remains committed to leveraging blockchain technology within its genomics platform while maintaining an Ethereum accumulation strategy as part of its treasury management. Moss...
2025-02-25 9:00 AM EST
Moss Genomics Announces Private Placement and Agreement to Acquire Ethereum
Vancouver, British Columbia--(Newsfile Corp. - February 3, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000 (the "Offering"). The Offering may close in one or more tranches and is subject to the approval of the Canadian Securities Exchange (the "Exchange"). Additionally, the Company may pay finders' fees in...
2025-02-03 7:24 PM EST
Moss Genomics Announces Closing of Private Placement, Acquisition of 160 Ethereum Cryptocurrency (ETH) and Welcomes Hunter Jordan to Its Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - January 31, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to announce that is has closed its previously announced non-brokered private placement of 2,500,000 common shares (each a "Share") at $0.10 per Share for total gross proceeds of $250,000 (the "Offering"). Concurrently, with the closing of the Offering, the Company announces closing of its acquisition of 160 Ethereum cryptocurrency ("ETH") in...
2025-01-31 7:31 PM EST
Moss Genomics Provides Corporate Update and Announces Shift in Business Strategy
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss") is pleased to provide an update on the Company's operations and business strategy. Corporate Update Further to the Company's news release dated December 24, 2024, the Company anticipates closing its non-brokered private placement of 2,500,000 common shares at a price of $0.10 per common share (the "Private Placement") for gross proceeds to the Company of...
2025-01-24 4:20 PM EST
Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)
Vancouver, British Columbia--(Newsfile Corp. - January 14, 2025) - Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the "Company" or "Moss Genomics") is pleased to announce that it has successfully listed its shares on the Frankfurt Stock Exchange (FSE) under the ticker symbol F73. This significant milestone marks a pivotal step in the Company's expansion and enhances its global visibility within the European investment community. This listing follows the company's recent accomplishments, including...
2025-01-14 7:00 AM EST
Canadian Company Moss Genomics Announces Agreement to Acquire Ethereum, Appoints Jack Liu as CEO and Director, Private Placement and Option Grant
Vancouver, British Columbia--(Newsfile Corp. - December 24, 2024) - Moss Genomics Inc. (CSE: MOSS) (the "Company" or "Moss") today announced the appointment of Jack Liu as CEO and a Director of the Company and the launch of its Moss Ethereum treasury division. The Company has entered into an arms-length asset purchase agreement dated December 24, 2024 to acquire 160 ETH for its treasury at a price of CDN$4,900 per ETH in exchange for the issuance of 7,840,000 common shares, at a deemed price...
2024-12-24 1:00 PM EST
Moss Genomics Inc. Welcomes Martin Bajic to Its Board
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2024) - Moss Genomics Inc. (CSE: MOSS) (the "Company" or "Moss") is pleased to announce that it has appointed Martin Bajic to its Board of Directors. Mr. Bajic replaces Dr. Min Seob Lee, who has resigned as a Director. The Company extends its best wishes to Dr. Lee and thanks him for his service as a member of the Board of Directors. On behalf of the Board of Directors, "Mark Tommasi" Director About Moss Genomics Moss is a biotechnology...
2024-07-18 4:40 PM EDT
Moss to Launch Revolutionary 90-Second Urine Test and Smartphone App
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), an innovator in the health technology industry, is thrilled to announce that it expects to launch its groundbreaking 90-second urine test and accompanying smartphone app in December 2023. This revolutionary product is set to transform the way individuals monitor their health and detect potential medical conditions, offering quick, accurate, and convenient results at...
2023-09-19 8:00 AM EDT
Moss Introduces Diet and Vitamin Reports
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia announces the introduction of its diet and vitamin reports (the "Reports") which can be ordered directly to your home via our online platform. Up to 80 million genetic variants are analyzed to provide the most insightful information concerning dietary needs and vitamin deficiencies. Our...
2023-06-16 8:00 AM EDT
Moss Genomics and Proteic Bioscience Sign Memorandum of Understanding
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces signing of a memorandum of understanding ("MOU") with Proteic Bioscience Inc. ("Proteic"). The MOU outlines an essential understanding of a proposed collaboration between Moss and Proteic to design a suite of new protein structures for the development of commercial supplements...
2023-05-15 8:00 AM EDT
Moss Introduces New Pain and Inflammation Report
Vancouver, British Columbia--(Newsfile Corp. - April 26, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia announces the introduction of its Pain and Inflammation report which can be ordered directly to your home via the Company's online platform Inflammation is one way our body fights infection, injury, and disease. Sometimes, due to some specific mutations, inflammation can become much more...
2023-04-26 8:30 AM EDT
Moss Introduces Cognitive Health Test
Vancouver, British Columbia--(Newsfile Corp. - April 5, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, BC announces the introduction of its Cognitive Health Test which can be ordered directly to your home via the Company's online platform. Moss's Cognitive Health report assesses the genetic markers associated with the ability to clearly think, learn, and remember. This report can be purchased digitally by...
2023-04-05 8:30 AM EDT
Moss Introduces New Gut Microbiome Test
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2023) - Moss Genomics Inc. (CSE: MOSS) ("Moss" or the "Company"), a consumer genomics and gut microbiome company based in Vancouver, British Columbia, announces the introduction of its Gut Microbiome test which can be ordered directly to your home via the Company's online platform. The gut microbiome is home to trillions of microbes that directly influence a person's mood, how they digest food and how their immune system responds to...
2023-03-28 8:30 AM EDT